A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for

Updated 06/21/2024

Status Completed

Clinical Trial Summary

To preliminary assess the efficacy and safety of recombinant human growth hormone injection on the treatment of small for gestational age (SGA), and determine the best dose.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Small for Gestational Age Infant

Clinical Trial Details

NCT number	NCT03221933
Study type	Interventional
Source	GeneScience Pharmaceuticals Co., Ltd.
Contact
Status	Completed
Phase	Phase 2
Start date	December 2009

See also
	Status	Clinical Trial	Phase
	Completed	`NCT05059093` - Developing and Testing AI Models for Fetal Biometry and Amniotic Volume Assessment in Fetal Ultrasound Scans.
	Recruiting	`NCT02375620` - Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature	Phase 2
	Not yet recruiting	`NCT05043753` - "Fetal gRowth AbnorMality dEtection Trial"	N/A
	Not yet recruiting	`NCT05070234` - Genetic Diagnosis and Human Growth Hormone Treatment in Small for Gestational Age Children With Short Stature
	Active, not recruiting	`NCT05343403` - Parental Participation on the Neonatal Ward - the neoPARTNER Study
	Not yet recruiting	`NCT05436119` - Select Nutrient and Gene Variant Analysis in a Targeted Diet and Lifestyle Intervention Reduces Preterm Birth
	Recruiting	`NCT04315545` - Pregnancy Outcomes and Maternal Insulin Sensitivity
	Recruiting	`NCT03245333` - A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA)	Phase 3
	Not yet recruiting	`NCT04050488` - Zinc Supplementation on Very Low Birth Weight Infant	Phase 4
	Recruiting	`NCT05144035` - A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants	Phase 4